1. Home
  2. Corporate Information
  3. Access

Corporate Information

Access

  • Head Office

    Address: 8F Daiwa Meieki Bldg., 1-21-19 Meieki Minami, Nakamura-ku, Nagoya, 450-0003, Japan

    On foot:

    JR Nagoya Station Sakura-dori exitTwo blocks to the south from Sasashima intersection (Approx. 9 minutes)

  • Discovery Research

    Address: Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-8601, Japan


    <Biology>
    Research Institute of Environmental Medicine
    Institute for Advanced Research Hall 2F


    <Chemistry>
    National Innovation Complex (NIC) 8F


    By train:

    Nagoya Subway Station (the Higashiyama Line)Motoyama Station (16 minutes)Transfer to the Meijo Line (Clockwise)Nagoya University Station (Approx. 2 minutes) Exit 2

Page Top

Corporate Information
CEO Message
Company Overview
Vision, Management Principle and Culture
Quality Policy
Corporate Governance
Business Model
Origins of Our Corporate Name and Logo
Access
Press Release
Research & Development
Collaboration
Partnering in Research
What are Research Tools?
Research Tool Licensing
Product Information
Anidulafungin
Ziprasidone
Dalbavancin
Potassium-Competitive Acid Blocker
5-HT4 Partial Agonist
5-HT2B Antagonist
Motilin Receptor Agonist
Licensing Status
Shareholder and Investor Information
Vision, Management Principle and Culture
Corporate Governance
Outline of Securities Matters
IR Library
IR Calendar
Disclaimer
IR Related News
Understanding RaQualia Pharma! RaQualia FAQ
RaQualia's History
What does RaQualia Pharma do?
How Does RaQualia Earn Revenues?
What About Dividends?
What are RaQualia's strengths?
What Does the Future Hold for RaQualia Pharma?
Contributions to Society
Corporate Contributions
Contributions to the Community
Press Release
Topics